# A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation

> **NCT05514119** · PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 6 (actual)

## Conditions studied

- Liver Transplant

## Interventions

- **DRUG:** Fenofibrate

## Key facts

- **NCT ID:** NCT05514119
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-17
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Low Enrollment
- **Last updated:** 2025-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05514119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05514119, "A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05514119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*